Science Explorer Interactive view Map

Charles Colcock Jones

Charles Colcock Jones publishes mostly in Immunology and Genetics, on topics such as T-cell and B-cell Immunology, Immunodeficiency and Autoimmune Disorders and Chronic Lymphocytic Leukemia Research.

World rank
#154,862
of 1,633,909 ranked researchers
Rank in United States
#64,785
of 358,040
Works
66
Citations
4
Citations per work
0.1

What does Charles Colcock Jones research?

Immunology: 66.7%Genetics: 33.3%67%top field
Immunology66.7%Genetics33.3%

Shares of their own output, by the field each of their topics belongs to. The grey slice is everything not listed.

  1. 1Immunology67% of their works
  2. 2Genetics33% of their works

Research topics

Which keywords describe Charles Colcock Jones's research?

The keywords of their largest research topics: Chronic Lymphocytic Leukemia, Foxp3, Genetic Mutations, Genomic Aberrations, Primary Immunodeficiency and TGF-ß.

Size is their works in the topics tagged with each word, from their 3 largest topics. Each links to the topic it comes from most.

All 6 words, with their numbers
  1. Chronic Lymphocytic Leukemia11 topic
  2. Foxp311 topic
  3. Genetic Mutations11 topic
  4. Genomic Aberrations11 topic
  5. Primary Immunodeficiency11 topic
  6. TGF-ß11 topic

Where does Charles Colcock Jones work?

Charles Colcock Jones's main affiliation in the publication record is United States Naval Academy, United States.

How many publications and citations does Charles Colcock Jones have?

Science Explorer counts 66 works and 4 citations for Charles Colcock Jones, ranking #154,862 of 1,633,909 researchers worldwide on the composite score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics are in the interactive view on the map. Is this your page? Request a correction or removal.